Question 1

Does Point72 Asset Management own PTGX stock?

Accepted Answer

No. Point72 Asset Management exited its PTGX (Protagonist Therapeutics) position in Q4 2024. Its Q3 2024 13F listed 214,872 shares worth $9.7M.

Question 2

How many shares of PTGX does Point72 Asset Management own?

Accepted Answer

None since Q4 2024, when Point72 Asset Management exited the position. Its Q3 2024 13F listed 214,872 shares worth $9.7M.

Question 3

What is Point72 Asset Management's PTGX position worth?

Accepted Answer

Point72 Asset Management's PTGX position was worth $9.7M in its Q3 2024 13F, before the exit in Q4 2024.

Question 4

Is Point72 Asset Management buying or selling PTGX?

Accepted Answer

In Q4 2024, Point72 Asset Management exited its entire PTGX position.

Question 5

When did Point72 Asset Management first buy PTGX?

Accepted Answer

Point72 Asset Management first reported PTGX in its Q3 2019 13F and listed it in 15 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2024-Q4 Latest	Exited	0	-100.0%	$0	0.0%	$38.60	0
2024-Q3	Decreased	214,872	-76.4%	$9.7M	0.0%	$45.00	0